Company profile: Abide Therapeutics
1.1 - Company Overview
Company description
- Provider of pharmaceutical research and drug development focused on serine hydrolase inhibitors.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Abide Therapeutics
Schwa-Medico
HQ: Germany
Website
- Description: Provider of equipment for non-medicinal pain therapy, medical aids and muscle stimulation, as well as transformers in industrial technology; distributes related medical equipment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Schwa-Medico company profile →
Theralase
HQ: Canada
Website
- Description: Provider of biopharmaceutical therapies including Anti-Cancer Therapy (ACT) using light-activated photo dynamic compounds to destroy cancer cells; Cool Laser Therapy (CLT) for knee pain relief by reducing inflammation and accelerating healing; a Phase II NMIBC clinical study of TLD-1433; and Rutherrin, an intravenous combination of TLD-1433 with transferrin to target and destroy cancer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Theralase company profile →
Tetra Bio-Pharma
HQ: Canada
Website
- Description: Provider of cannabinoid-derived drug development for inflammation, pain, ophthalmology, and oncology, including treatments targeting sepsis, acute respiratory distress syndrome, cytokine release syndrome, breakthrough and uncontrolled cancer pain, uveitis, proliferative vitreoretinopathy, chemotherapy-induced nausea and vomiting, cancer cachexia, and hepatocellular carcinoma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tetra Bio-Pharma company profile →
SPR Therapeutics
HQ: United States
Website
- Description: Provider of advanced peripheral nerve stimulation (PNS) solutions for pain management, including the SPRINT PNS System—a minimally invasive, drug-free 60-day treatment delivering significant and sustained relief from chronic and acute pain without a permanent implant—and training events for interventional pain management physicians on ultrasound and fluoroscopic imaging and hands-on lead implantation using the system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SPR Therapeutics company profile →
Nufabrx
HQ: United States
Website
- Description: Provider of blemish-fighting pillowcases hand-crafted from natural bamboo fibers and infused with natural ingredients and clinically proven natural remedies for antibacterial, antimicrobial benefits during sleep; and pain-relieving compression sleeves (knee, ankle, wrist, calf, arm, lower leg) combining medicine with compression for 150+ hours of use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nufabrx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Abide Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Abide Therapeutics
2.2 - Growth funds investing in similar companies to Abide Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Abide Therapeutics
4.2 - Public trading comparable groups for Abide Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →